<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02987192</url>
  </required_header>
  <id_info>
    <org_study_id>MICS2016033</org_study_id>
    <nct_id>NCT02987192</nct_id>
  </id_info>
  <brief_title>Minimally Invasive Lumbar Aneasthesia Used for Cesarean Section</brief_title>
  <official_title>Comparison of the Impact Between Minimally Invasive and Traditional Spinal Anesthesia for Cesarean Section in Maternal Anticoagulation Therapy:Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal canal anesthesia is marked the most commonly used method of cesarean section.
      Traditional spinal anesthesia may cause post-dural puncture headache and low back pain.Plenty
      of parturients are undergoing anticoagulation therapy.They may be forced to accept general
      anesthesia in order to avoid epidural hematoma.Therefore, we propose minimally invasive
      spinal anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Traditional group patients will receive cutting type 22 gauge needles, while minimally
      invasive group patients will receive pen type 27 gauge needles.Patients will be blinded to
      the intervention allocations. Spinal anesthesia will be performed with a standardized
      technique. Lumbar puncture will be performed through an interspace (L3-4 or L2-3) with
      patients in a lateral decubitus position. After free flow of cerebrospinal fluid through the
      needle tip be verified, 2ml ropivacaine will be injected. We will record puncture situation,
      anesthesia plane and measure post-dural puncture headache, post-operative back pain and
      epidural hematoma.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue score of post-dural puncture headache</measure>
    <time_frame>1 to 7 days after operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue score of low back pain</measure>
    <time_frame>1 to 7 days after operation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anticoagulation</condition>
  <condition>Minimally Invasive</condition>
  <condition>Spinal Anesthesia</condition>
  <arm_group>
    <arm_group_label>traditional group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traditional group patients will receive cutting type 22 gauge needles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>minimally invasive group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>minimally invasive group patients will receive pen type 27 gauge needles</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pen type 27 gauge needles</intervention_name>
    <description>minimally invasive group patients will receive pen type 27 gauge needles.</description>
    <arm_group_label>minimally invasive group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cutting type 22 gauge needles</intervention_name>
    <description>traditional group patients will receive cutting type 22 gauge needles.</description>
    <arm_group_label>traditional group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. puerpera accept anticoagulation therapy

          2. American society of anesthesiologists(ASA) classification I to II level

          3. Willing to participate in this study and signed an informed consent

          4. pregnancy at least 37 weeks

        Exclusion Criteria:

          1. platelet count less than 50*100000000

          2. International Normalized Ratio more than 1.5

          3. site of puncture with infection

          4. with intracranial hypertension

          5. with lumbar spine or spinal cord disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>WEIFENG YU, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Anesthesiology Department Renji Hospital, Shanghai Jiao Tong University, School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DAN HUANG, MS</last_name>
    <phone>15921108822</phone>
    <email>huangdan363@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>JIE ZHOU, MS</last_name>
    <phone>13601693227</phone>
    <email>zhoujie1486@renji.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Renji Hospital, Shanghai Jiao Tong University, School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DAN HUANG, MS</last_name>
      <phone>15921108822</phone>
      <email>huangdan363@163.com</email>
    </contact>
    <contact_backup>
      <last_name>JIE ZHOU, MS</last_name>
      <phone>13601693227</phone>
      <email>zhoujie1486@renji.com</email>
    </contact_backup>
    <investigator>
      <last_name>DAN HUANG, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2016</study_first_submitted>
  <study_first_submitted_qc>December 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2016</study_first_posted>
  <last_update_submitted>July 1, 2017</last_update_submitted>
  <last_update_submitted_qc>July 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RenJi Hospital</investigator_affiliation>
    <investigator_full_name>DAN HUANG</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>spinal anesthesia</keyword>
  <keyword>anticoagulation</keyword>
  <keyword>minimally invasive</keyword>
  <keyword>Cesarean Section</keyword>
  <keyword>Maternal</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

